Joaquín Martínez-López, Javier De la Cruz, Rodrigo Gil-Manso, Adrián Alegre, Javier Ortiz, Pilar Llamas, Yolanda Martínez, José-Ángel Hernández-Rivas, Isabel González-Gascón, Celina Benavente, Pablo Estival Monteliu, Víctor Jiménez-Yuste, Miguel Canales, Mariana Bastos, Mi Kwon, Susana Valenciano, Marta Callejas-Charavia, Javier López-Jiménez, Pilar Herrera, Rafael Duarte, Lucía Núñez Martín-Buitrago, Pedro Sanchez Godoy, Cristina Jacome Yerovi, Pilar Martínez-Barranco, María García Roa, Cristian Escolano Escobar, Arturo Matilla, Belén Rosado Sierra, María Concepción Aláez-Usón, Keina Quiroz-Cervantes, Carmen Martínez-Chamorro, Jaime Pérez-Oteyza, Rafael Martos-Martinez, Regina Herráez, Clara González-Santillana, Juan Francisco Del Campo, Arancha Alonso, Adolfo de la Fuente, Adriana Pascual, Rosalía Bustelos-Rodriguez, Ana Sebrango, Elena Ruiz, Eriel Alexis Marcheco-Pupo, Carlos Grande, Ángel Cedillo, Carlos Lumbreras, Andrés Arroyo Barea, José Manuel Casas-Rojo, Maria Calbacho, José Luis Diez-Martín, Julio García-Suárez
Mortality rates for COVID-19 have declined over time in the general population, but data in patients with hematologic malignancies are contradictory. We identified independent prognostic factors for COVID-19 severity and survival in unvaccinated patients with hematologic malignancies, compared mortality rates over time and versus non-cancer inpatients, and investigated post COVID-19 condition. Data were analyzed from 1166 consecutive, eligible patients with hematologic malignancies from the population-based HEMATO-MADRID registry, Spain, with COVID-19 prior to vaccination roll-out, stratified into early (February-June 2020; n = 769 (66%)) and later (July 2020-February 2021; n = 397 (34%)) cohorts...
February 27, 2023: Cancers